期刊文献+

脂联素与冠心病类型和心血管危险因素的关系 被引量:26

The relationship between adiponectin and the type of coronary heart disease and the relationship between adiponectin and cardiovascular risk factors
原文传递
导出
摘要 目的:明确冠心病(CHD)患者脂联素(APN)水平是否下降,确定低APN血症是否是CHD的危险因素及APN水平与CHD类型和心血管危险因素间的关系。方法:117例研究对象分为对照组(CO)、稳定型心绞痛组(SAP)和急性冠状动脉综合征(ACS)组。SAP、ACS组与CO组进行比较了解CHD患者APN水平;比较不同类型患者的APN水平以确定APN水平与CHD类型间的关系;经logistic回归分析确定低APN血症是否是CHD的危险因素;比较合并某一心血管危险因素者与不合并者的APN水平,了解心血管危险因素对APN水平的影响。结果:CO组、SAP组、ACS组3组比较APN呈降低趋势(10.61±3.38,6.98±3.18,4.59±3.69,P<0.05);逐步logistic回归分析结果显示低APN血症(OR值=0.788,p=0.041)、高胆固醇血症(OR值=5.096,p=0.009)为CHD患病的独立危险因素;超重或肥胖、血脂异常、男性、吸烟、合并3个及3个以上危险因素的CHD患者APN水平降低(P<0.05),合并高血压和糖尿病者APN水平无明显下降。结论:CHD患者APN水平下降,ACS患者APN水平较SAP患者进一步下降。低APN血症是CHD的危险因素。肥胖、吸烟、男性、血脂异常可使APN水平下降,且合并心血管危险因素多者APN水平进一步降低。 Objective:To investigate whether concentrations of adiponectin (APN) decrease and constitute a significant coronary risk factor,with focus on the relation between plasma concentrations of APN and risk factor of coronary heart disease (CHD).Methods:The total of 117 patients were divided into three groups,there were the controlled (CO) group (n=30),stable angina pectoris (SAP) group (n=26) and acute coronary syndrome (ACS) group (n=61),comparing the concentration of APN among them. Analysis with multiple logistic regression to observe whether low adiponectin concentration is a risk factor of CHD. Compare the concentration of APN between CHD with and without the coronary risk factor.Results:Concentrations of adiponectin in patients with coronary heart disease were significantly lower than in the control group ,and concentrations of adiponectin in patients with ACS were lower than those in patients with SAP. Low adiponectin concentration correlated with the development of CHD. Additionally,multiple logistic regression analysis showed that low adiponectin concentration was a risk factor of CHD. The concentration of APN without the coronary risk factor was lower. Conclusion:The concentration of adiponectin was lower in CHD,and may be related to the development of CHD. The low concentration of adiponectin was the risk factor of CHD.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第1期11-14,共4页 Journal of Clinical Cardiology
基金 宁夏卫生厅重点项目(No:W200643)
关键词 冠心病 脂联素 心血管危险因素 coronary heart disease adiponectin cardiovascular risk factors
  • 相关文献

参考文献14

  • 1NAKAMURA Y,SHIMADA K,FUKUDA D,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery[J].Heart,2004,90:528-533.
  • 2裴强,秦永文,吴弘,郑兴,丁继军.血清脂联素水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2004,20(10):619-621. 被引量:33
  • 3葛庆峰,闫杰.急性心肌梗死患者血清脂联素水平的动态变化[J].临床荟萃,2005,20(11):601-603. 被引量:13
  • 4KUMADA M,KIHARA S,OUCHI N,et al.Adiponectin specifically increased tisse inhibitor of metalloproteinnase-1 through interleukin-10 expression in human macrophages[J].Circulation,2004,109:2046-2049.
  • 5KUMADA M,KIHARA S,SUMITSUJI S,et al.Association of hypoadiponectiemia with coronary artery disease in men arteriosclerosis[J].Thromb Vasc Biol,2003,23:85-89.
  • 6SOYDINC S,DAVUTOGLU V,SARI I.High serum levels of adiponectin improve coronary collateral development in patients with coronary artery disease[J].Tohoku J Exp Med,2007,211:347-352.
  • 7GONON A T,WIDEGREN U,BULHAK A,et al.Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase,Akt and nitric oxide[J].Cardiovasc Res,2008,78:116-122.
  • 8CNOP M,HAVEL P J,UTZSCHNEIDER K M,et al.Relationship of adiponectin to body fat distribution,insulin sensitivity and plasma lipoproteins:evidence for independent roles of age and sex[J].Diabetologia,2003,46:459-459.
  • 9PAJVANI U B,DU X,COMBS T P,et al.Structure function studies of the adipocyte secreted hormone Acrp30/adiponectin.Implications for metabolic regulation and bioactivity[J]J Biol Chem,2003,278:9073-9085.
  • 10MIYAZAKI T,SHIMADA K,MO KUNO H,et al.Adipocyte derived plasma protein,adiponectin,is associated with smoking status in patients with coronary artery disease[J].Heart,2003,89:663-663.

二级参考文献16

  • 1叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2000.313.
  • 2Arita Y, Kihara S, Ouchi N,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun, 1999, 257: 79-83.
  • 3Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specificprotein, adiponectin. in type 2 diabetic patients. Arterioscler Thromb Vase Biol,2000, 20:1595-1599.
  • 4Matsubara M, Maruoka S, Katayose S. Decreased Plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002 ,87: 2764-2769.
  • 5Kumada M, Kihara S, Sumitsuji S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler, Thromb Vasc Biol, 2003,23: 85 -89.
  • 6Engeli S. Feldpausch M, Girzekbeak K, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003 ,52:942-947.
  • 7Matsuda M. Shimomura 1. Sara M, et al. Role of adi ponectin in preventing vascular stenosis. J Biol Chem,2002, 277:37487-37491.
  • 8Kubota N. Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277:25863-25866.
  • 9Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protain, adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001 ,103:1057- 1063.
  • 10Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFκB signaling through a cAMP dependent pathway. Cir culation, 2000,102:1296-1301.

共引文献44

同被引文献284

引证文献26

二级引证文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部